Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: A SEER‐Medicare analysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|4|492-498

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.4, 2014-02, pp. : 492-498

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lymph node identification following neoadjuvant therapy in rectal cancer: A stage‐stratified analysis using the surveillance, epidemiology, and end results (SEER)‐medicare database

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 22-4790, Iss. 4, 2015-08 ,pp. : 415-420

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lymph node identification following neoadjuvant therapy in rectal cancer: A stage‐stratified analysis using the surveillance, epidemiology, and end results (SEER)‐medicare database

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 112, Iss. 4, 2015-08 ,pp. : 415-420

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influence of tumor response and treatment schedule on the distribution of tumor recurrence in esophageal cancer patients treated with neoadjuvant chemoradiotherapy

By  

JOURNAL OF SURGICAL ONCOLOGY, Vol. 116, Iss. 8, 2017-12 ,pp. : 1096-1102

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of neoadjuvant chemoradiotherapy on postoperative morbidity and mortality associated with esophageal cancer

By  

DISEASES OF THE ESOPHAGUS (ELECTRONIC), Vol. 28, Iss. 4, 2015-05 ,pp. : 358-364

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improved survival using intensity‐modulated radiation therapy in head and neck cancers: A SEER‐Medicare analysis

By  

CANCER, Vol. 120, Iss. 5, 2014-03 ,pp. : 702-710

John Wiley & Sons Inc

Access to resources Recommend Favorite